The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
XOLAIR omalizumab (rch) 150mg powder for injection vial with diluent ampoule (82744)
ARTG Name
XOLAIR omalizumab (rch) 150mg powder for injection vial with diluent ampoule
Product name
XOLAIR omalizumab (rch) 150mg powder for injection vial with diluent ampoule
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
Omalizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information